Literature DB >> 21292501

The type I interferon system in the development of lupus.

Lars Rönnblom1, Gunnar V Alm, Maija-Leena Eloranta.   

Abstract

The type I interferon (IFN) system induces inhibition of viral replication, but can also activate the innate and adaptive immune system. An important role of the type I IFN system in autoimmune diseases, including lupus, is suggested by the observation that these disorders display a prominent over-expression of type I IFN regulated genes. The development of autoimmune diseases in some individuals treated with IFN-α directly supports a pivotal role for this cytokine in breaking tolerance and inducing autoimmune reactions. A genetic setup that promotes type I IFN production and/or response and the presence of endogenous inducers of IFN-α production have been described in patients with lupus. Several known environmental risk factors for development of lupus or disease flares may contribute to the ongoing type I IFN production. In the present review we will describe the possible role of the type I IFN system in the lupus disease process. The possible connection between the type I IFN system and some environmental and genetic risk factors for lupus is also discussed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292501     DOI: 10.1016/j.smim.2011.01.009

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  75 in total

1.  [Anti-interferon alpha therapy of systemic lupus erythematosus].

Authors:  C Specker
Journal:  Z Rheumatol       Date:  2013-10       Impact factor: 1.372

Review 2.  TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes.

Authors:  Melissa Swiecki; Stephen A McCartney; Yaming Wang; Marco Colonna
Journal:  J Leukoc Biol       Date:  2011-08-15       Impact factor: 4.962

Review 3.  dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity.

Authors:  Yaming Wang; Melissa Swiecki; Stephen A McCartney; Marco Colonna
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

Review 4.  New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.

Authors:  Daniel J Wallace; Vineet S Gudsoorkar; Michael H Weisman; Swamy R Venuturupalli
Journal:  Nat Rev Rheumatol       Date:  2012-07-17       Impact factor: 20.543

Review 5.  Type I interferon in the pathogenesis of lupus.

Authors:  Mary K Crow
Journal:  J Immunol       Date:  2014-06-15       Impact factor: 5.422

6.  Production and characterization of thirteen human type-I interferon-α subtypes.

Authors:  Srilalitha Kuruganti; Mary Ann Accavitti-Loper; Mark R Walter
Journal:  Protein Expr Purif       Date:  2014-08-20       Impact factor: 1.650

7.  Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

Authors:  Lina Wirestam; Helena Enocsson; Thomas Skogh; Leonid Padyukov; Andreas Jönsen; Murray B Urowitz; Dafna D Gladman; Juanita Romero-Diaz; Sang-Cheol Bae; Paul R Fortin; Jorge Sanchez-Guerrero; Ann E Clarke; Sasha Bernatsky; Caroline Gordon; John G Hanly; Daniel Wallace; David A Isenberg; Anisur Rahman; Joan Merrill; Ellen Ginzler; Graciela S Alarcón; W Winn Chatham; Michelle Petri; Munther Khamashta; Cynthia Aranow; Meggan Mackay; Mary Anne Dooley; Susan Manzi; Rosalind Ramsey-Goldman; Ola Nived; Kristjan Steinsson; Asad Zoma; Guillermo Ruiz-Irastorza; Sam Lim; Ken Kalunian; Murat Inanc; Ronald van Vollenhoven; Manuel Ramos-Casals; Diane L Kamen; Søren Jacobsen; Christine Peschken; Anca Askanase; Thomas Stoll; Ian N Bruce; Jonas Wetterö; Christopher Sjöwall
Journal:  J Rheumatol       Date:  2019-01-15       Impact factor: 4.666

8.  Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus.

Authors:  Lino L Teichmann; Dominik Schenten; Ruslan Medzhitov; Michael Kashgarian; Mark J Shlomchik
Journal:  Immunity       Date:  2013-03-14       Impact factor: 31.745

9.  The role of microparticles in the generation of immune complexes in murine lupus.

Authors:  Anirudh J Ullal; David S Pisetsky
Journal:  Clin Immunol       Date:  2012-10-13       Impact factor: 3.969

10.  Kinetic analysis of cytokine-mediated receptor assembly using engineered FC heterodimers.

Authors:  Ashlesha Deshpande; Balananda-Dhurjati Kumar Putcha; Srilalitha Kuruganti; Mark R Walter
Journal:  Protein Sci       Date:  2013-06-06       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.